DocDollars

Covis Pharma GMBH

Switzerland · Reporting entity ID 100000316823

Total reported 2019–2025
$3.33M
#849 of 2,960 reporting companies — 0% of all reported industry payments
$260K in general payments across 7,736 records, plus $3.07M in research funding across 21 records.

How it breaks down

General payments $260,263
Research funding $3,073,103

Where this comes from

Figures are from the CMS Open Payments “payments grouped by reporting entity” dataset, queried live. Reporting entities are applicable manufacturers and group purchasing organisations required to report under the Sunshine Act.

Summary

Covis Pharma GMBH reported $3.33M to US doctors and teaching hospitals from 2019 to 2025, ranking #849 of 2,960 reporting companies. 92% of that was research funding and 8% general payments such as consulting, speaking, food and travel. 7,736 general payment records and 21 research records were filed.

Common questions about Covis Pharma GMBH

How much has Covis Pharma GMBH paid US doctors?

Covis Pharma GMBH reported $3,333,366 to US physicians and teaching hospitals across the 2019–2025 Open Payments program years: $260,263 in general payments, $3,073,103 in research funding.

How does Covis Pharma GMBH rank among drug and device companies?

It ranks #849 of 2,960 reporting entities by total reported value, about 0% of all industry payments in the dataset.

Does a payment from Covis Pharma GMBH mean a doctor did something wrong?

No. Open Payments records transfers of value such as speaking fees, consulting, meals, travel and research funding. The data shows the relationship, not its effect on prescribing or care.